Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters

Myocardial Ischemia Clinical Trials

A listing of Myocardial Ischemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (22) clinical trials

EU Multicenter Registry to Assess Outcomes in CABG Patients: Treatment of Vascular Conduits With DuraGraft [VASC]

Objectives (i) To evaluate the Safety and Performance of DuraGraft (ii) To characterize the use of DuraGraft and the outcomes of patients whose vascular grafts were treated with DuraGraft in daily clinical routine (iii) To further characterize the incidence of MACCE outcomes associated with CABG in patients whose vascular grafts ...

Phase N/A

A clinical research study for the treatment of Coronary Artery Disease, Coronary heart disease

This will be a prospective, observational study designed to include a convenience sample of all qualifying patients undergoing myocardial CTP. The study will enroll patients who have undergone a clinically indicated CCTA for suspicion of coronary artery disease and have a suspected coronary stenosis 50%-69% on that examination. CCTA is ...

Phase N/A

A Phase 4 clinical study for patients with Atrial Fibrillation, Coronary Artery Disease, Acute Coronary Syndrome, Coronary heart disease

Patients with atrial fibrillation (AF) presenting an acute coronary syndrome (ACS) and undergoing PCI require a triple therapy with a combination of oral anticoagulation (OAC) and dual anti-platelet therapy. Current guidelines recommend a regimen consisting of aspirin, clopidogrel and an oral anticoagulant. Although effective in preventing recurrent ischemia, triple therapy ...


A clinical trial seeking patients for a research study for the treatment of Myocardial Infarction, Coronary Artery Disease, Ischemic Heart Disease, Coronary heart disease

Percutaneous coronary intervention (PCI) is the main stream of treatment of coronary artery disease. Drug-eluting stents (DES) have dramatically reduced the rates of restenosis and target lesion revascularization (TLR) compared with bare-metal stents (BMS). Newer-generation DES with a durable polymer such as Xience (Abbott, US) and Resolute (Medtronic, US) were ...

Phase N/A

Evaluating the Role of Coronary Artery Disease to Resolve the Diagnosis of Type 2 Myocardial Infarction

The investigators will systematically evaluate the mechanisms of acute myocardial injury in unselected patients who present to hospital with an alternative primary illness likely to cause myocardial oxygen supply or demand imbalance. All patients will be assessed by a member of the study team during their index admission and will ...

Phase N/A

A clinical research study of Placebo Oral Tablet, Spironolactone

an interventional study to measure the possible effects of spironolactone ( an aldosterone antagonist) on the incidence of acute kidney injury after coronary angiography


Mainz Intracoronary Database. The Coronary Slow-flow and Microvascular Diseases Registery

Patients included in the registry will be contacted by telephone at 3,6,9, 12 months and 2, 5, 10 years after the procedure. In case coronary slow flow is shown at the index procedure, 39ml of blood will be drawn for further studies.

Phase N/A

Patients are needed to participate in a clinical research study for the treatment of Non ST Segment Elevation Myocardial Infarction, Coronary Artery Disease, Ischemic Heart Disease, Coronary heart disease

This trial will evaluate Orbital Atherectomy compared to conventional balloon angioplasty technique for the treatment of severely calcified lesions prior to implantation of drug-eluting stents (DES).

Phase N/A

Post-marketing Registry of Inspiron Sirolimus Eluting Coronary Stent

Up to 5.0000 patients with native coronary arteries lesions with diameter between 2.5 and 4.0 mm and 34 mm of length treated solely with the Inspiron Sirolimus Eluting Coronary Stent. Stent implantation should be performed according to the Instructions for Use and according to the local practice. It is recommended ...

Phase N/A

Patients are needed to participate in a clinical research study to evaluate Aortic Stenosis, Coronary Artery Disease, TAVI, Protein C Inhibitor, Coronary heart disease

The aim of this study is to evaluate the effect of routine FFR-guided complete revascularization with PCI compared to conservative management in patients with concomitant coronary artery disease who are undergoing TAVI.

Phase N/A